Pharma-Bio Serv, Inc. (OTCQB:PBSV), a consulting firm specializing in compliance and project management for the pharmaceutical and biotechnology sectors, announced its financial results for the quarter ended January 31, 2026. The company reported revenues of approximately $2.3 million, which reflects a decrease of about $0.2 million compared to the same quarter in the previous year. However, the net income for the quarter was $32,860, marking an improvement of $24,324 from the prior year’s quarter. CEO Mr. Sanchez expressed optimism regarding the company's strategic priorities, emphasizing operational efficiency and client relationship strengthening as key focuses moving forward. The company aims to maintain disciplined cost management and align its resources with areas of greatest opportunity, positioning itself for long-term value creation for shareholders. The results were disclosed in a press release dated March 17, 2026, as part of the company's 8-K filing with the SEC.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.